IMMY18128 / Seattle / Brea Lipe
Research Question:
Is SEA-BCMA tan effective treatment for multiple myeloma (MM) and what side effects
(unwanted effects) may occur?
Basic Study Information
Purpose:
This trial will study SEA-BCMA to find out whether it is an effective treatment for
multiple myeloma (MM) and what side effects (unwanted effects) may occur.
The study will have two parts. In the first part, participants get SEA-BCMA by itself.
This part of the study will find out how much SEA-BCMA should be given for treatment
and how often. It will also find out how safe the treatment is and how well it works.
In the second part of the study, participants will be given both SEA-BCMA and dexamethasone.
Dexamethasone is a drug that can be used to treat multiple myeloma. The part will
study whether SEA-BCMA and dexamethasone are safe when used together.
Location: University of Rochester Medical Center
Study Reference #: IMMY18128
Lead Researcher (Principal Investigator)
Lead Researcher:
Brea Lipe
Study Contact Information
Study Coordinator: Stephanie Short
Phone: +1 585-276-7885
Email: stephanie_short@urmc.rochester.edu
Additional Study Details
Trial Not Found
The study you are looking for is not active at this time.
Return to Search